Skip to main content
Clinical Trials/CTRI/2024/04/066551
CTRI/2024/04/066551
Not yet recruiting
未知

Prospective analyses of survival of patients with indeterminate lesions and unequivocal metastatic disease at presentation in Bone & Soft tissue sarcoma across all ages of patients presenting to BST DMG, agnostic of the intent of treatment and site of metastasis or burden of disease - METSARC

Tata Memorial Hospital0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Tata Memorial Hospital
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. patient of any age/sex who presents with indeterminate lesions, or unequivocal radiological metastasis
  • (including skip metastases), or biopsy proven synchronous metastatic disease in radiologically
  • equivocal cases, at presentation, stratified for Ewing’s Sarcoma, Osteosarcoma (all subtypes),
  • chondrosarcoma, Soft tissue sarcoma (round cell and NRSTS, including radiation induced sarcoma)
  • irrespective of intent of treatment.
  • 2\. Histopathological confirmation of primary sarcoma diagnosis at TMH
  • 3\. Imaging review of standard of care staging investigations at TMH or documented radiology consensus
  • at joint clinic appraisals for obvious metastases.
  • 4\. Indeterminate lesions based off validated radiologic criteria and consensus in multi\-disciplinary joint
  • clinic (subcentimetre lesions, equivocal characteristics, minimal impact, not amenable to biopsy).

Exclusion Criteria

  • 1\. Metachronous metastases (after a disease free/treatment free interval)
  • 2\. Absence of histopathological review at TMH
  • 3\. Absence of imaging review at TMH

Outcomes

Primary Outcomes

Not specified

Similar Trials